Europe Pharmaceutical Contract Manufacturing Market Share

Statistics for the 2023 & 2024 Europe Pharmaceutical Contract Manufacturing market share, created by Mordor Intelligence™ Industry Reports. Europe Pharmaceutical Contract Manufacturing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Europe Pharmaceutical Contract Manufacturing Industry

The Europe Pharmaceutical Contract Manufacturing market is a bit consolidated and consists of a few players. In terms of market share, top companies have control over the market. Major players include Fareva Holdings SA, Recipharm AB, Boehringer Ingelheim Group, Aenova Group, Famar SA, and Lonza Group, among others.

  • August 2022 - ACG will launch the German Process Development Laboratory in 2023. This new process development laboratory will be located at ACG's Xertecs GmbH site in Mulheim in the South West of Germany, with the first phase occupying approximately 250 square meters.
  • March 2022 - Evonik built a new cGMP facility in Hanau, Germany, to manufacture lipids for clinical development and launch innovative medicines. The new facility can support customers by producing all custom and proprietary lipids, including PEGylated lipids, phospholipids, and ionizable cationic lipids. The start of operation is planned for the beginning of 2023.

Europe Pharmaceutical Contract Manufacturing Market Leaders

  1. Fareva Holding SA

  2. Recipharm AB

  3. Boehringer Ingelheim Group

  4. Aenova Group

  5. Famar SA

*Disclaimer: Major Players sorted in no particular order

Europe Pharmaceutical Contract Manufacturing Market Concentration

Europe Pharmaceutical Contract Manufacturing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)